Active	Status	Sponsor type	Region	Phase	Filter
3 Active 11 Inactive 14 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
InfaSurf (calfactant) / Samaritan Pharma, Ony Biotech, AbbVie
Aero-05, NCT05960929: InfasurfAero™ Versus Sham Treatment in Preterm Newborns with RDS	Recruiting	3	220	US	Infasurf Aero™	ONY, Avania	Respiratory Distress Syndrome (Neonatal), Intubation Complication, Death; Neonatal	01/26	04/26
NCT04056741: Administration of Surfactant Through an Instillation Device Infasurf® (Calfactant) in Neonates- A Pilot Study	Suspended	2	55	US	surfactant airway device	ONY	RDS of Prematurity, Surfactant Protein B Deficiency, Chronic Lung Disease	12/25	03/26
NCT03582930: Aerosolized Infasurf Treatment Protocol: Aerosolized Infasurf for Spontaneously Breathing Patients With Early RDS (AERO-03)	No Longer Available	N/A		US	Infasurf Aero	ONY	Neonatal Respiratory Distress

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
InfaSurf (calfactant) / Samaritan Pharma, Ony Biotech, AbbVie
Aero-05, NCT05960929: InfasurfAero™ Versus Sham Treatment in Preterm Newborns with RDS	Recruiting	3	220	US	Infasurf Aero™	ONY, Avania	Respiratory Distress Syndrome (Neonatal), Intubation Complication, Death; Neonatal	01/26	04/26
NCT04056741: Administration of Surfactant Through an Instillation Device Infasurf® (Calfactant) in Neonates- A Pilot Study	Suspended	2	55	US	surfactant airway device	ONY	RDS of Prematurity, Surfactant Protein B Deficiency, Chronic Lung Disease	12/25	03/26
NCT03582930: Aerosolized Infasurf Treatment Protocol: Aerosolized Infasurf for Spontaneously Breathing Patients With Early RDS (AERO-03)	No Longer Available	N/A		US	Infasurf Aero	ONY	Neonatal Respiratory Distress